Skip survey header

9937 TTT Live Evaluation

Gene Therapy in Hemophilia: ISTH HTC Train-The-Trainer Live Sessions

1. Codon optimization of transgene cDNA constructs results in: *This question is required.
2. In the schematic of the adeno-associated virus genome below, which element(s) is/are replaced to make an AAV therapeutic vector for gene therapy? *This question is required.
3. Of the current clinical trials for hemophilia gene therapy, what is the longest duration of post-infusion follow-up? *This question is required.
4. Which of the following statements about liver transaminase elevations in gene therapy trials is NOT correct? *This question is required.
DEMOGRAPHICS
7. What is your role in the care of individuals with hemophilia? Select all that apply *This question is required.
Please rate BEFORE this activity: *This question is required.
Space Cell 0 - Not Relevant1 - Low2345 - High
KNOWLEDGE of gene therapy approaches in development for hemophilia A and B:
ABILITY to discuss with patients the efficacy and durability observed in recent clinical trials for gene therapy in hemophilia:
KNOWLEDGE of the adverse events associated with the clinical trials for gene therapy in hemophilia:
Please rate AFTER this activity: *This question is required.
Space Cell 0 - Not Relevant1 - Low2345 - High
KNOWLEDGE of gene therapy approaches in development for hemophilia A and B:
ABILITY to discuss with patients the efficacy and durability observed in recent clinical trials for gene therapy in hemophilia:
KNOWLEDGE of the adverse events associated with the clinical trials for gene therapy in hemophilia:
PRACTICAL APPLICATION
10. Do you intend to make changes or apply new knowledge to your practice as a result of this activity? *This question is required.
*If yes or possibly considering changes, please check off what you intend to do differently or incorporate into your clinical management of patients as a result of this educational activity. Select all that apply: *This question is required.
SATISFACTION
 
Was the format of this educational activity appropriate for the content presented? *This question is required.
11. Did this educational activity meet your learning needs? *This question is required.
Was this activity scientifically sound and free of commercial bias or influence? *This question is required.
FOR EUROPEAN UNION AND UNITED KINGDOM LEARNERS ONLY:
The France Foundation would like to email you educational opportunities relevant to your practice to the address you provided. May we have your consent?